Overview

Pharmacokinetics of Sugammadex for the Reversal of Moderate Neuromuscular Blockade in Patients During Renal Transplantation

Status:
Recruiting

Trial end date:
2022-11-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to illustrate pharmacokinetics of sugammadex in reversal of rocuronium-induced moderate neuromuscular blockade in patients during renal transplantation

Phase:

Phase 4

Details

Lead Sponsor:

Guangzhou General Hospital of Guangzhou Military Command

Collaborator:

Guangdong Provincial Hospital of Traditional Chinese Medicine